≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Kela reimbursement Agammaglobulinemia (D80-84)

DOID MESH PheWeb

D3_KELA_IMMUDEF

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

KELA reimbursements: KELA codes 120

196

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

196

diagram downward connector

Check minimum number of events None

196

diagram downward connector

Include endpoints None

196

diagram downward connector
D3_KELA_IMMUDEF

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 196 125 71
Unadjusted prevalence (%) 0.06 0.06 0.05
Mean age at first event (years) 42.50 44.55 38.91

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: D3_KELA_IMMUDEF – Kela reimbursement Agammaglobulinemia (D80-84)
GWS hits:

Survival analyses between endpoints

↥

Plot

before Kela reimbursement Agammaglobulinemia (D80-84)
after Kela reimbursement Agammaglobulinemia (D80-84)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Kela reimbursement Agammaglobulinemia (D80-84)

↥